Filing Details

Accession Number:
0001567619-21-016236
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-23 17:02:05
Reporting Period:
2021-08-19
Accepted Time:
2021-08-23 17:02:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Innoviva Inc. INVA Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1750085 Marianne Zhen 1350 Old Bayshore Highway, Suite 400
Burlingame CA 94010
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-08-19 2,802 $16.02 36,493 No 4 S Direct
Common Stock Acquisiton 2021-08-20 1,129 $15.89 35,364 No 4 S Direct
Common Stock Disposition 2021-08-20 760 $15.94 34,604 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 F Direct
Footnotes
  1. The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.